Neurocrine Biosciences
NBIX
#1464
Rank
NZ$26.48 B
Marketcap
NZ$260.53
Share price
-1.19%
Change (1 day)
10.05%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company